Pricing Log in Create free account

Decoy Therapeutics Inc (DCOY) vs Onconetix, Inc. (ONCO)

Decoy Therapeutics Inc and Onconetix, Inc. are both Biotechnology companies. Decoy Therapeutics Inc and Onconetix, Inc. are of similar size ($2.9M and $2.9M). Onconetix, Inc. trades at the lower P/E: 0.0× against 0.0×. Onconetix, Inc. grew revenue faster over the last twelve months: −51.3% against −60.5%. Decoy Therapeutics Inc has the higher net margin (−698.8% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 18 metrics below, Onconetix, Inc. leads on 13 and Decoy Therapeutics Inc on 5.

Valuation

Metric DCOY ONCO Biotechnology median
P/E 0.01 0.00 8.50
P/S 0.30 1.67 9.71
P/B 0.14 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.49 0.29 0.64
EV/Sales (3.48) (7.35) 9.21
Earnings yield 15,691.12% 51,691.67% (33.15%)
Free cash flow yield (1,677.54%) (960.15%) (25.50%)

Profitability

Metric DCOY ONCO Biotechnology median
Gross margin 10.57% 80.38% 65.16%
Operating margin (706.88%) (2,524.73%) 0.00%
Net margin (698.79%) (1,578.60%) 0.00%
Free cash flow margin (432.43%) (1,595.90%) 0.00%
Return on equity (827.77%) (105.23%) (56.36%)
Return on assets (278.04%) (57.37%) (48.04%)
Return on invested capital 0.00% (135.42%) 0.00%

Growth

Metric DCOY ONCO Biotechnology median
Revenue growth (TTM) (60.49%) (51.33%) 6.02%
EPS growth (last fiscal year) (85.66%) 99.09% 30.26%
Revenue growth, 5-year CAGR 12.73% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DCOY ONCO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.83 2.21 4.72
Net debt to EBITDA 0.85 0.29 0.96

Dividend

Metric DCOY ONCO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DCOY ONCO Biotechnology median
Market cap 2.93m 2.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack